<sup>1</sup>H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(<i>p</i>-MeC<sub>6</sub>H<sub>4</sub><i><sup>i</sup></i>Pr)<sub>2</sub>Ru<sub>2</sub>(SC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Bu<i><sup>t</sup></i>)<sub>3</sub>]<sup>+</sup> (DiRu-1)

<sup>1</sup>H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(<i>p</i>-MeC<sub>6</sub>H<sub>4</sub><i><sup>i</sup></i>Pr)<sub>2</sub>Ru<sub>2</sub>(SC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Bu<i><sup>t</sup></i>)<sub>3</sub>]<sup>+</sup> (DiRu-1)

The trithiolato bridged diruthenium complex DiRu-1 [(<i>p</i>-MeC<sub>6</sub>H<sub>4</sub><i><sup>i</sup></i>Pr)<sub>2</sub>Ru<sub>2</sub>(SC<sub>6</sub>H<sub>4</sub>-<i>p</i>-Bu&l...

Full description

Bibliographic Details
Main Authors: Hedvika Primasová, Lydia E. H. Paul, Gaëlle Diserens, Ester Primasová, Peter Vermathen, Martina Vermathen, Julien Furrer
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Metabolites
Subjects:
ovarian cancer
cytotoxicity
ruthenium complex
HR-MAS NMR
NMR metabolomics
A2780
cis-Pt resistant
metal-based drugs
Online Access:https://www.mdpi.com/2218-1989/9/7/146

Similar Items

Similar Items